Status:
COMPLETED
Efficacy of XP20B Following Bunionectomy Surgery
Lead Sponsor:
Xanodyne Pharmaceuticals
Conditions:
Acute Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if XP20B is an effective treatment for the relief of pain following bunionectomy surgery.
Eligibility Criteria
Inclusion
- having undergone bunionectomy surgery
- having achieved the requisite level of pain
Exclusion
- pregnant or lactating
- history of substance abuse
- clinically significant condition or lab abnormality
- taken any prohibited medications
- gastrointestinal bleeding or history of
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2008
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT00655291
Start Date
April 1 2008
End Date
August 1 2008
Last Update
October 8 2008
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigatve Site
Anaheim, California, United States, 92810
2
Investigative Site
Owings Mills, Maryland, United States, 21117
3
Investigative Site
Austin, Texas, United States, 78705
4
Investigative Site
Houston, Texas, United States, 78705